Literature DB >> 20038618

Detection of KPC in Acinetobacter spp. in Puerto Rico.

Iraida E Robledo1, Edna E Aquino, María I Santé, Jorge L Santana, Diana M Otero, Carlos F León, Guillermo J Vázquez.   

Abstract

During an island-wide PCR-based surveillance study of beta-lactam resistance in multidrug-resistant (MDR) Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter calcoaceticus-baumannii complex isolates obtained from 17 different hospitals, 10 KPC-positive Acinetobacter isolates were identified. DNA sequencing of the bla(KPC) gene identified KPC-2, -3, and -4 and a novel variant, KPC-10. This is the first report of a KPC-type beta-lactamase identified in Acinetobacter species.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20038618      PMCID： PMC2825984          DOI： 10.1128/AAC.00899-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  29 in total

1.  Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases.

Authors:  Neil Woodford; Elizabeth J Fagan; Matthew J Ellington
Journal:  J Antimicrob Chemother       Date:  2005-11-10       Impact factor: 5.790

2.  In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia.

Authors:  R Insa; E Cercenado; M J Goyanes; A Morente; E Bouza
Journal:  J Antimicrob Chemother       Date:  2007-01-09       Impact factor: 5.790

3.  Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.

Authors:  Harald Seifert; Danuta Stefanik; Hilmar Wisplinghoff
Journal:  J Antimicrob Chemother       Date:  2006-09-14       Impact factor: 5.790

4.  OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Laurent Poirel; Sophie Marqué; Claire Héritier; Christine Segonds; Gérard Chabanon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 5.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Authors:  L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

6.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

Review 7.  Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.

Authors:  Eliahu Bishburg; Kathryn Bishburg
Journal:  Int J Antimicrob Agents       Date:  2009-08-08       Impact factor: 5.283

Review 8.  How long do nosocomial pathogens persist on inanimate surfaces? A systematic review.

Authors:  Axel Kramer; Ingeborg Schwebke; Günter Kampf
Journal:  BMC Infect Dis       Date:  2006-08-16       Impact factor: 3.090

9.  Multidrug-resistant Acinetobacter baumannii.

Authors:  Aharon Abbo; Shiri Navon-Venezia; Orly Hammer-Muntz; Tami Krichali; Yardena Siegman-Igra; Yehuda Carmeli
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

10.  Multidrug-resistant Acinetobacter extremity infections in soldiers.

Authors:  Kepler A Davis; Kimberly A Moran; C Kenneth McAllister; Paula J Gray
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883
View more
  74 in total

1.  First description of KPC-2-producing Pseudomonas putida in Brazil.

Authors:  Anna C S Almeida; Marinalda A Vilela; Felipe L S Cavalcanti; Willames M B S Martins; Marcos A Morais; Marcia M C Morais
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

2.  Role of ISKpn7 and deletions in blaKPC gene expression.

Authors:  Thierry Naas; Gaelle Cuzon; Ha-Vy Truong; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

Review 3.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

4.  Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam.

Authors:  Krystyna M Kazmierczak; Douglas J Biedenbach; Meredith Hackel; Sharon Rabine; Boudewijn L M de Jonge; Samuel K Bouchillon; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

5.  First report of Klebsiella oxytoca strain coproducing KPC-2 and IMP-8 carbapenemases.

Authors:  Bin Li; Jing-Yong Sun; Qing-Zhong Liu; Li-Zhong Han; Xin-Hong Huang; Yu-Xing Ni
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

Review 6.  Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues.

Authors:  Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

7.  Direct detection and genotyping of Klebsiella pneumoniae carbapenemases from urine by use of a new DNA microarray test.

Authors:  Harald Peter; Kathrine Berggrav; Peter Thomas; Yvonne Pfeifer; Wolfgang Witte; Kate Templeton; Till T Bachmann
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

Review 8.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

9.  KPC presence in Pseudomonas aeruginosa has minimal impact on the in vivo efficacy of carbapenem therapy.

Authors:  Mao Hagihara; Jared L Crandon; Carl M Urban; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

10.  Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae testing susceptible to cefepime by reference methods.

Authors:  Renata C Picão; Ronald N Jones; Rodrigo E Mendes; Mariana Castanheira
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.